Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?

摘要

The high rate of discrepancy between primary tumor and nodal metastasis phenotype imposes the need for a comparative assessment of both primary tumor and nodal metastasis before any therapeutic decision, in order to avoid recurrence and to improve patient prognosis and overall survival.